Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid

British Journal of Dermatology

Volumn 151, Issue 1, 2004, Pages 126-131

  Sakuma Oyama, Y ^a   Powell, A M ^a   Oyama, N ^a   Albert, S ^a   Bhogal, B S ^a   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Adhesion molecule; Autoantigen; Autoimmune response; Bullous pemphigoid; Hemidesmosome; Type XVII collagen

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RELIABILITY; SERODIAGNOSIS;

AGED; AGED, 80 AND OVER; AUTOANTIGENS; CASE-CONTROL STUDIES; COLLAGEN TYPE VII; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; SENSITIVITY AND SPECIFICITY;

EID: 4043089858     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06082.x     Document Type: Article

References (18)

1. Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1993; 53: 291-325.
2. Ishiko A, Shimizu H, Kikuchi A et al. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993; 91: 1608-15.
3. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992; 99: 243-50.
4. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996; 288: 507-9.
5. Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92: 2480-8.
6. Sitaru C, Schmidt E, Petermann S et al. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 2002; 118: 664-71.
7. Kobayashi M, Amagai M, Kuroda-Kinoshita K et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30: 224-32.
8. Giudice GJ, Wilske KC, Anhalt GJ et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 1994; 102: 878-81.
9. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998; 139: 365-70.
10. Zillikens D, Mascaro JM, Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997; 109: 679-83.
11. Hata Y, Fujii Y, Tsunoda K, Amagai M. Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression. J Dermatol Sci 2000; 23: 183-90.
12. Haase C, Budinger L, Borradori L et al. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998; 110: 282-6.
13. 2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119: 1065-73.
14. Bhogal BS, Black MM. Diagnosis, diagnostic and research techniques. In: Management of Blistering Diseases (Wojnorowska F, Briggaman RA, eds). London: Chapman & Hall Ltd, 1990: 15-34.
15. Kidd IM, Emery VC. The use of baculoviruses as expression vectors. Appl Biochem Biotechnol 1993; 42: 137-59.
16. Amo Y, Ohkawa T, Tatsuta M et al. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2001; 26: 14-18.
17. Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-8.
18. Hall RP III, Murray JC, McCord MM et al. Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid. J Invest Dermatol 1993; 101: 9-14.